1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About

Suzhou Huayi Lejian Biotechnology Co., Ltd.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2019

Location

Suzhou Jiangsu China

Primary Industry

Biotechnology

About

Established in 2019 and based in Suzhou, China, Suzhou Huayi Lejian Biotechnology Co., Ltd. is a biotechnology company that focuses on biopharmaceutical. In February 2018, the company raised an undisclosed amount in strategy investment from Tencent Investment, Skycus Capital, Guangkong Dongtai Investment Management and Gaorong Capital. The company also established a research and development center in Beijing. The company has developed an efficient vector platform and its products which can be used in the field of hemophilia A and has entered the clinical trial stage. The company has also launched an AAV gene therapy platform, whose products are in clinical trials. The company also built a cGMP production base is a chain of new drug development and production experimental platform with plasmid and virus development, production and quality control functions. The company will promote the manufacturing, registration, clinical and research of the company's lead gene therapy products, as well as accelerate the development of the company's products in other targeted liver and targeted neuro areas.
Current Investors
Tencent Investment, Gaorong Ventures, Guangkong Dongtai Investment Management

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.